Current HIV Research

Author(s): Oguzhan Acet*, Sukru Dirik, Husnu Pullukcu, Meltem Tasbakan and Deniz Gokengin

DOI: 10.2174/011570162X314456241114055019

DownloadDownload PDF Flyer Cite As
The Impact of the COVID-19 Pandemic on Syphilis: A Retrospective Study among the Ege University HIV Cohort

Page: [395 - 401] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Introduction/Objective: The SARS-CoV-2 pandemic has led to significant changes in the lives, habits, and frequency of hospital admissions of People Living with HIV (PLWH). However, information is limited on the changes in the sexual behavior of these individuals and the resulting Sexually Transmitted Infections (STIs). This study aimed to determine the trends in syphilis among the Ege University HIV cohort before and during the pandemic.

Methods: All PLWH who presented to the HIV outpatient clinic of Ege University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, for HIV care for the first time between January 1st, 2008 and October 1st, 2022, and whose laboratory results for syphilis were available, were reviewed. Those presenting between January 1st, 2008, and March 11th, 2020, were defined as the pre-pandemic (group A) cases, and those presenting between March 12th, 2020, and October 1st, 2022, were defined as the pandemic period (group B) cases. Clinical and laboratory information about the cases was obtained retrospectively from medical records.

Results: The number of PLWH who presented to the clinic for a first visit with a new HIV diagnosis or follow-up between the specified dates was 1283 (956 group A, 327 group B). Overall, 155 (12.1%) PLWH were diagnosed with syphilis. A total of 204 syphilis episodes occurred during 6,173 Person-years of Follow-up (PYFU). Of these episodes, 86 (42.1%) were diagnosed in the pre-pandemic period, and 118 (57.8%) during the pandemic. The number of episodes during the pandemic was significantly higher in group A than in the pre-pandemic period (3.47 per 100 PYFU and 2.57 per 100 PYFU, respectively; p=0.0434). When comparing the number of episodes during the pandemic period, compared to group A, group B members had a significantly higher number of syphilis episodes during the pandemic (3.47 and 7.81 per 100 PYFU, respectively; p<.001).

Conclusion: This study shows that syphilis rates remained high during the pandemic. Healthcare providers are recommended to prepare PLWH for potential emergencies to be encountered in the future and repeatedly remind them to use prevention in all high-risk circumstances.

Keywords: HIV, syphilis, COVID-19, pandemic, PLWH, SARS-CoV-2.

Graphical Abstract

[1]
Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. 2022. Available from: https://www.who.int/publications/i/item/9789240053779
[2]
Geretti AM, Mardh O, de Vries HJC, et al. Sexual transmission of infections across Europe: Appraising the present, scoping the future. Sex Transm Infect 2022; 98(6): 451-7.
[http://dx.doi.org/10.1136/sextrans-2022-055455] [PMID: 35537800]
[3]
Roberts CP, Klausner JD. Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men. Expert Rev Anti Infect Ther 2016; 14(11): 1037-46.
[http://dx.doi.org/10.1080/14787210.2016.1236683] [PMID: 27626361]
[4]
Zheng Y, Ye K, Ying M, et al. Syphilis epidemic among men who have sex with men: A global systematic review and meta-analysis of prevalence, incidence, and associated factors. J Glob Health 2024; 14: 04004.
[http://dx.doi.org/10.7189/jogh.14.04004] [PMID: 38236688]
[5]
Tsuboi M, Evans J, Davies EP, et al. Prevalence of syphilis among men who have sex with men: A global systematic review and meta-analysis from 2000–20. Lancet Glob Health 2021; 9(8): e1110-8.
[http://dx.doi.org/10.1016/S2214-109X(21)00221-7] [PMID: 34246332]
[6]
Kassie TD, Wasihun Y, Aschale A, Ambaw F. Lived experience of people on anti-retro viral therapy in the context of covid-19: A phenomenological study. PLoS One 2023; 18(11): e0286292.
[http://dx.doi.org/10.1371/journal.pone.0286292] [PMID: 37917729]
[7]
Gleason N, Banik S, Braverman J, Coleman E. The impact of the COVID-19 pandemic on sexual behaviors: Findings from a national survey in the United States. J Sex Med 2021; 18(11): 1851-62.
[http://dx.doi.org/10.1016/j.jsxm.2021.08.008] [PMID: 34535369]
[8]
Nimbi FM, Cavagnis S, Eleuteri S. Changes in sexual behavior and satisfaction and violent behavior during COVID-19 lockdown: Explorative results from the Italian cross-sectional study of the I-SHARE multi-country project. Int J Environ Res Public Health 2024; 21(1): 96.
[http://dx.doi.org/10.3390/ijerph21010096] [PMID: 38248559]
[9]
Mourikis I, Kokka I, Koumantarou-Malisiova E, Kontoangelos K, Konstantakopoulos G, Papageorgiou C. Exploring the adult sexual wellbeing and behavior during the COVID-19 pandemic. A systematic review and meta-analysis. Front Psychiatry 2022; 13: 949077.
[http://dx.doi.org/10.3389/fpsyt.2022.949077] [PMID: 36061280]
[10]
Chone JS, Lima SVMA, Fronteira I. Factors associated with chemsex in Portugal during the COVID-19 pandemic. Rev Lat Am Enfermagem 2021; 29: e3474.
[http://dx.doi.org/10.1590/1518-8345.4975.3474] [PMID: 34468628]
[11]
Berzkalns A, Thibault CS, Barbee LA, Golden MR, Khosropour C, Kerani RP. Decreases in reported sexually transmitted infections during the time of COVID-19 in king county, WA: Decreased transmission or screening? Sex Transm Dis 2021; 48(8S): S44-9.
[http://dx.doi.org/10.1097/OLQ.0000000000001463] [PMID: 33967230]
[12]
Ren M, Dashwood T, Walmsley S. The intersection of HIV and syphilis: Update on the key considerations in testing and management. Curr HIV/AIDS Rep 2021; 18(4): 280-8.
[http://dx.doi.org/10.1007/s11904-021-00564-z] [PMID: 34091858]
[13]
Chia CC, Chao CM, Lai CC. Diagnoses of syphilis and HIV infection during the COVID-19 pandemic in Taiwan. Sex Transm Infect 2021; 97(4): 319.
[http://dx.doi.org/10.1136/sextrans-2020-054802] [PMID: 33082234]
[14]
Nemli SA, Yigit I, Agrali B, Gokengin D, Turan B. Living with HIV during COVID-19: Knowledge and worry about COVID-19, adherence to COVID-19-related precautions, and HIV health outcomes. AIDS Care 2023; 35(5): 639-42.
[http://dx.doi.org/10.1080/09540121.2022.2148156] [PMID: 36435963]
[15]
Mäki-Koivisto V, Sinikumpu SP, Jokelainen J, Aho-Laukkanen E, Junttila IS, Huilaja L. Impact of COVID-19 pandemic on the incidence of sexually transmitted infections in Northern Finland in 2019 to 2022. Acta Derm Venereol 2022; 102: adv00795.
[http://dx.doi.org/10.2340/actadv.v102.3401] [PMID: 36200507]
[16]
Lőrincz K, Meznerics FA, Jobbágy A, et al. STIs during the COVID-19 pandemic in Hungary: Gonorrhea as a potential indicator of sexual behavior. Int J Environ Res Public Health 2022; 19(15): 9627.
[http://dx.doi.org/10.3390/ijerph19159627] [PMID: 35954984]
[17]
Stanford KA, Almirol E, Schneider J, Hazra A. Rising syphilis rates during the COVID-19 pandemic. Sex Transm Dis 2021; 48(6): e81-3.
[http://dx.doi.org/10.1097/OLQ.0000000000001431] [PMID: 33783406]
[18]
Vasalou V, Paparizos V, Daskalakis E, Paparizou E, Kourkounti S, Stratigos A. Syphilis and gonorrhoea among people with HIV during pandemic times: A report from Athens, Greece. Sex Transm Infect 2021; 97(8): 627.
[http://dx.doi.org/10.1136/sextrans-2021-055095] [PMID: 34413200]
[19]
López Corbeto E, Lugo Colón R, Montoro Fernández M, Casabona Barbara J. Epidemiological situation of post-pandemic sexually transmitted infections in Catalonia, Spain. Med Clin (Barc) 2023; 161(3): 95-100.
[PMID: 37244853]
[20]
Janier M, Unemo M, Dupin N, Tiplica GS, Potočnik M, Patel R. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol 2021; 35(3): 574-88.
[http://dx.doi.org/10.1111/jdv.16946] [PMID: 33094521]
[21]
Masoudi M, Maasoumi R, Bragazzi NL. Effects of the COVID-19 pandemic on sexual functioning and activity: A systematic review and meta-analysis. BMC Public Health 2022; 22(1): 189.
[http://dx.doi.org/10.1186/s12889-021-12390-4] [PMID: 35086497]
[22]
Prabhu S, Poongulali S, Kumarasamy N. Impact of COVID-19 on people living with HIV: A review. J Virus Erad 2020; 6(4): 100019.
[http://dx.doi.org/10.1016/j.jve.2020.100019] [PMID: 33083001]
[23]
Mohammed AH, Blebil A, Dujaili J, Rasool-Hassan BA. The risk and impact of COVID-19 pandemic on immunosuppressed patients: Cancer, HIV, and solid organ transplant recipients. AIDS Rev 2020; 22(3): 151-7.
[http://dx.doi.org/10.24875/AIDSRev.20000052] [PMID: 33118527]
[24]
Chenneville T, Gabbidon K, Hanson P, Holyfield C. The impact of COVID-19 on HIV treatment and research: A call to action. Int J Environ Res Public Health 2020; 17(12): 4548.
[http://dx.doi.org/10.3390/ijerph17124548] [PMID: 32599783]
[25]
Darcis G, Vaira D, Moutschen M. Impact of coronavirus pandemic and containment measures on HIV diagnosis. Epidemiol Infect 2020; 148: e185.
[http://dx.doi.org/10.1017/S0950268820001867] [PMID: 32829742]
[26]
Chow EPF, Ong JJ, Denham I, Fairley CK. HIV testing and diagnoses during the COVID-19 pandemic in Melbourne, Australia. J Acquir Immune Defic Syndr 2021; 86(4): e114-5.
[http://dx.doi.org/10.1097/QAI.0000000000002604] [PMID: 33346567]
[27]
Fernàndez-López L, Simões D, Casabona J, et al. Impact of the COVID-19 pandemic on community-based testing for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Eur J Public Health 2023; 33(3): 528-35.
[http://dx.doi.org/10.1093/eurpub/ckad010] [PMID: 36928984]
[28]
Seara-Morais GJ, Pousada BF, Escaleira FF, Doi AM, Welter EAR, Avelino-Silva VI. Mobility restrictions during the COVID-19 pandemic and reduced outpatient HIV and syphilis testing in Brazil. Braz J Infect Dis 2023; 27(3): 102771.
[http://dx.doi.org/10.1016/j.bjid.2023.102771] [PMID: 37088105]
[29]
Hyndman I, Nugent D, Whitlock GG, McOwan A, Girometti N. COVID-19 restrictions and changing sexual behaviours in HIV-negative MSM at high risk of HIV infection in London, UK. Sex Transm Infect 2021; 97(7): 521-4.
[http://dx.doi.org/10.1136/sextrans-2020-054768] [PMID: 33462118]
[30]
Kowalska JD, Skrzat-Klapaczyńska A, Bursa D, et al. HIV care in times of the COVID-19 crisis - Where are we now in Central and Eastern Europe? Int J Infect Dis 2020; 96: 311-4.
[http://dx.doi.org/10.1016/j.ijid.2020.05.013] [PMID: 32413608]
[31]
Köksal MO, Beka H, Evlice O. Syphilis seroprevalence among HIV-infected males in Istanbul, Turkey. Rev Argent Microbiol 2020; 52(4): 266-71.
[http://dx.doi.org/10.1016/j.ram.2020.01.002] [PMID: 32178940]
[32]
Aydın ÖA, Karaosmanoğlu HK, Sayan M, İnce ER, Nazlıcan Ö. Seroprevalence and risk factors of syphilis among HIV/AIDS patients in Istanbul, Turkey. Cent Eur J Public Health 2015; 23(1): 65-8.
[http://dx.doi.org/10.21101/cejph.a4001] [PMID: 26036101]
[33]
Sarigül F, Sayan M, İnan D, et al. Current status of HIV/AIDS-syphilis co-infections: A retrospective multicentre study. Cent Eur J Public Health 2019; 27(3): 223-8.
[http://dx.doi.org/10.21101/cejph.a5467] [PMID: 31580558]
[34]
Begovac J, Romih Pintar V, Vrsaljko N, et al. Incidence, risk factors, and clinical findings of syphilis among men living with HIV in Croatia during the COVID-19 pandemic. Sci Rep 2023; 13(1): 11784.
[http://dx.doi.org/10.1038/s41598-023-38807-1] [PMID: 37479770]
[35]
Bížová B, Rob F, Třešňák Hercogová J. Increase of early syphilis cases during the COVID-19 pandemic in the Czech Republic. Sex Transm Infect 2022; 98(3): 231.
[http://dx.doi.org/10.1136/sextrans-2021-055098] [PMID: 34039745]
[36]
Roux P, Donadille C, Girard G, Spire B, Protière C, Velter A. Impact of COVID-19 pandemic on men who have sex with men that practice chemsex in France: Results from the national ERAS web survey. Am J Men Health 2022; 16(1): 15579883211073225.
[http://dx.doi.org/10.1177/15579883211073225] [PMID: 35156425]
[37]
Jacobson L, Regan A, Heidari S, Onyango MA. Transactional sex in the wake of COVID-19: Sexual and reproductive health and rights of the forcibly displaced. Sex Reprod Health Matters 2020; 28(1): 1822493.
[http://dx.doi.org/10.1080/26410397.2020.1822493] [PMID: 33032502]
[38]
Brown JRG, Reid D, Howarth AR, et al. Changes in STI and HIV testing and testing need among men who have sex with men during the UK’s COVID-19 pandemic response. Sex Transm Infect 2022; 99(4): sextrans-2022-055429.
[http://dx.doi.org/10.1136/sextrans-2022-055429] [PMID: 35863887]